EMEA Requests Stronger Liver Disorder Warnings For Ketek
This article was originally published in The Pink Sheet Daily
Executive Summary
The European Medicines Agency has asked Sanofi-Aventis to revise product labeling for its antibiotic Ketek (telithromycin) to include stronger warnings about liver disorders